Atorvastatin (Lipitor 20 mg): Uses, Muscle Safety and Interactions

Uses and what the tablet represents

Lipitor 20 mg is an oral tablet containing atorvastatin, a statin that reduces cholesterol production in the liver. The reviewed US information describes treatment of specified lipid disorders and reduction of cardiovascular events in selected people at risk. It is used alongside appropriate lifestyle measures; the goal depends on the patient’s cardiovascular history and lipid results.

This page concerns the Lipitor tablet rather than another statin or a combination product. A 20 mg strength does not identify the right treatment intensity for every person. Cholesterol usually cannot be judged from how someone feels, so follow-up blood tests and clinical review remain important even when there are no symptoms.

Side effects and symptoms that need attention

Diarrhoea, nausea, joint discomfort and muscle symptoms can occur. Report unexplained muscle pain, tenderness or weakness promptly, especially with fever, unusual tiredness or dark urine: rare muscle breakdown can affect the kidneys. Persistent muscle weakness needs assessment even if another clinician has already advised stopping the medicine.

Yellowing of the eyes or skin, significant upper abdominal pain, dark urine or unusual fatigue can indicate liver injury. The US label advises liver testing before treatment and when clinically indicated. Blood glucose can increase in some people. These possibilities require assessment of the individual benefit and risk, rather than assuming that every symptom is caused by the statin.

Interactions, pregnancy and breastfeeding

Certain antivirals, macrolide antibiotics and azole antifungals can increase atorvastatin exposure and muscle risk. Ciclosporin, some other cholesterol-lowering medicines and colchicine also need specific checks. Large quantities of grapefruit juice can increase exposure; the relevant amount and management should be discussed for the exact product and regimen. Do not apply another statin’s interaction instructions automatically.

Pregnancy wording here follows the current US approach. FDA removed the blanket pregnancy contraindication for statins in 2021, while advising that most pregnant patients should discontinue them under clinical supervision. A small group with very high cardiovascular risk may need a different decision. This does not establish routine pregnancy safety. The US Lipitor information does not recommend breastfeeding during treatment. Local product information may differ, so pregnancy, pregnancy planning or breastfeeding should trigger a prompt discussion with the prescriber.

Sources

• Lipitor: US prescribing information and patient information — US prescribing information revised April 2024; current DailyMed version checked 30 October 2026
• FDA: Removal of the strongest statin pregnancy warning, with continued precautions — FDA Drug Safety Communication, 20 July 2021; checked 30 October 2026
• NHS: Atorvastatin patient information — Official patient information on cholesterol treatment, follow-up and common adverse effects; checked 30 October 2026

Source check: 30 October 2026. This date records a check of published sources, not an independent clinical review. The current leaflet for your own product and advice from a qualified healthcare professional take priority for personal treatment.